Michelle A. Kelliher

16.9k citations

95 papers · 10.9k indexed · 3 hit papers · h-index 52

Molecular Biology top 0.5%
Immunology top 0.2%
Cancer Research top 0.5%
Oncology top 2%
Hematology top 0.5%

Co-authors: Philip Leder Stefan Grimm Yasumasa Ishida Ben Z. Stanger Frank C. Kuo Katherine A. Fitzgerald Thomas H. Lee Nicole Hermance
Topics: Immune Response and Inflammation (28 papers)NF-κB Signaling Pathways (24 papers)Acute Lymphoblastic Leukemia research (22 papers)
Cited by: Immunology Cancer Research Hematology
Journals: Nature Science Cell
Partner nations: United States Germany Canada

In The Last Decade

Michelle A. Kelliher

92 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal

1998 905 citations Michelle A. Kelliher et al. profile →
Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death

2018 800 citations Pontus Ørning, Dan Weng et al. Science profile →
RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation

2004 674 citations Michelle A. Kelliher et al. profile →

Peers

Countries citing papers authored by Michelle A. Kelliher

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Kelliher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Kelliher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Kelliher more than expected).

Fields of papers citing papers by Michelle A. Kelliher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Kelliher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Kelliher. The network helps show where Michelle A. Kelliher may publish in the future.

Co-authorship network of co-authors of Michelle A. Kelliher

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Kelliher. A scholar is included among the top collaborators of Michelle A. Kelliher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Kelliher. Michelle A. Kelliher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Raver1 links Ripk1 RNA splicing to caspase-8-mediated pyroptotic cell death, inflammation, and pathogen resistance 2025 ·Proceedings of the National Academy of Sciences ·(unknown),Pontus Ørning,(unknown),(unknown),(unknown),Roland Elling,Michelle A. Kelliher,John Bertin,Megan K. Proulx,Jon D. Goguen,Liv Ryan,Richard K. Kandasamy,Terje Espevik,Athma A. Pai,Katherine A. Fitzgerald,Egil Lien	2
2	Oncogenic dependency on SWI/SNF chromatin remodeling factors in T-cell acute lymphoblastic leukemia 2024 ·Leukemia ·(unknown),Tze King Tan,(unknown),(unknown),(unknown),Michelle A. Kelliher,Allen Eng Juh Yeoh,Takaomi Sanda,Shi Hao Tan	2
3	The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance 2024 ·Leukemia ·Kevin W. O’Connor,(unknown),(unknown),(unknown),(unknown),Justine E. Roderick,Keshab Kumar Karna,(unknown),Kai Hu,Haibo Liu,Rui Li,Michael A. Brehm,Lihua Julie Zhu,David J. Curtis,Cédric S. Tremblay,Michelle A. Kelliher	4
4	ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice 2024 ·Proceedings of the National Academy of Sciences ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Keshab Kumar Karna,(unknown),Joanne A. O’Donnell,Lucio H. Castilla,Jonathan Maelfait,Jan Rehwinkel,Michelle A. Kelliher	3
5	TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy 2023 ·Trends in Immunology ·Michelle A. Kelliher,Katherine A. Fitzgerald	4
6	T cell–derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death 2021 ·JCI Insight ·Nicholas Chun,(unknown),(unknown),Robert L. Fairchild,William M. Baldwin,(unknown),Jesse D. Gelles,Jerry E. Chipuk,Michelle A. Kelliher,Vasile I. Pavlov,Yansui Li,Dirk Homann,Peter S. Heeger,Adrian T. Ting	10
7	Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death 2020 ·Blood ·Justine E. Roderick,(unknown),(unknown),Kevin W. O’Connor,Katherine Tang,Boyao Zhang,Michael A. Brehm,Dale L. Greiner,Jun Yu,Lihua Julie Zhu,Michael R. Green,Michelle A. Kelliher	9
8	Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell deathbreakdown → 2018 ·Science ·Pontus Ørning,Dan Weng,Kristian K. Starheim,Dmitry Ratner,(unknown),Bettina Lee,(unknown),Shiyu Xia,Hao Wu,Michelle A. Kelliher,Scott B. Berger,Peter J. Gough,John Bertin,Megan K. Proulx,Jon D. Goguen,Nobuhiko Kayagaki,Katherine A. Fitzgerald,Egil Lien	800
9	NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263 2018 ·Clinical Cancer Research ·Anahita Dastur,(unknown),Carlotta Costa,(unknown),August Williams,Joseph McClanaghan,Max Greenberg,Justine E. Roderick,Neha U. Patel,(unknown),Ultan McDermott,Mathew J. Garnett,Jorge A. Almenara,Steven Grant,Kathryn Rizzo,Jeffrey A. Engelman,Michelle A. Kelliher,Anthony C. Faber,Cyril H. Benes	16
10	Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death 2018 ·Proceedings of the National Academy of Sciences ·Ricard Garcia‐Carbonell,Jerry Wong,Ju Youn Kim,Lisa Abernathy‐Close,Brigid S. Boland,(unknown),Philip A. Harris,Samuel B. Ho,Soumita Das,Peter B. Ernst,Roman Šášik,William J. Sandborn,John Bertin,(unknown),John T. Chang,Michelle A. Kelliher,David L. Boone,Mónica Gumá,Michael Karin	75
11	Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia 2018 ·Nature Medicine ·Nikos Kourtis,Charalampos Lazaris,Kathryn Hockemeyer,Juan Carlos Balandrán,(unknown),Jasper Mullenders,Yixiao Gong,Thomas Trimarchi,(unknown),Hai Hu,Liza Shrestha,Alberto Ambesi‐Impiombato,Michelle A. Kelliher,Elisabeth Paietta,Gabriela Chiosis,Mónica L. Guzmán,Adolfo A. Ferrando,Aristotelis Tsirigos,Iannis Aifantis	58
12	Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity 2017 ·The Journal of Immunology ·Joanne A. O’Donnell,(unknown),Justine E. Roderick,Dalia Martinez‐Marin,Matija Zelic,(unknown),Nicole Hermance,Stephen Lyle,Manolis Pasparakis,Katherine A. Fitzgerald,Ann Marshak‐Rothstein,Michelle A. Kelliher	29
13	Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis 2014 ·Proceedings of the National Academy of Sciences ·Justine E. Roderick,Nicole Hermance,Matija Zelic,Matthew J. Simmons,Apostolos Polykratis,Manolis Pasparakis,Michelle A. Kelliher	71
14	Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 2014 ·Cancer Discovery ·Tríona Ní Chonghaile,Justine E. Roderick,(unknown),Jeremy Ryan,Stephen E. Sallan,Lewis B. Silverman,Mignon L. Loh,Stephen P. Hunger,Brent L. Wood,Daniel J. DeAngelo,Richard M. Stone,Marian H. Harris,Alejandro Gutiérrez,Michelle A. Kelliher,Anthony Letai	190
15	A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage 2011 ·Molecular and Cellular Biology ·Yibin Yang,Fang Xia,Nicole Hermance,Angela M. Mabb,(unknown),(unknown),Pallavi Gandhi,Mary Munson,Shigeki Miyamoto,Michelle A. Kelliher	118
16	Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL 2011 ·Blood ·Jessica Tatarek,Kathleen Cullion,Todd Ashworth,Rachel M. Gerstein,Jon C. Aster,Michelle A. Kelliher	82
17	Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide 2009 ·The Journal of Experimental Medicine ·François Coulombe,Maziar Divangahi,Frédéric J. Veyrier,Louis de Léséleuc,James L. Gleason,Yibin Yang,Michelle A. Kelliher,Amit Kumar Pandey,Christopher M. Sassetti,Michael B. Reed,Marcel A. Behr	177
18	NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells 2006 ·Cancer Research ·(unknown),Kyle Draheim,Michelle A. Kelliher,Shigeki Miyamoto	21
19	p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice 2005 ·Oncogene ·(unknown),Kyle Draheim,Manoj Bhasin,Michelle A. Kelliher	21
20	Activating Notch1 mutations in mouse models of T-ALL 2005 ·Blood ·Jennifer O’Neil,Jennifer A. Calvo,Keith McKenna,Veena Krishnamoorthy,Jon C. Aster,Craig H. Bassing,Frederick W. Alt,Michelle A. Kelliher,A. Thomas Look	177

About Michelle A. Kelliher

Michelle A. Kelliher is a scholar working on Immunology, Hematology and Cancer Research, having authored 95 papers that have together received 10.9k indexed citations. Recurring topics across this work include Immune Response and Inflammation (28 papers), NF-κB Signaling Pathways (24 papers) and Acute Lymphoblastic Leukemia research (22 papers). The work is most often cited by research in Immunology (5.1k citations), Cancer Research (2.3k citations) and Hematology (1.4k citations). Michelle A. Kelliher has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Philip Leder, Stefan Grimm, Yasumasa Ishida, Ben Z. Stanger, Frank C. Kuo, Katherine A. Fitzgerald, Thomas H. Lee, Nicole Hermance, Manolis Pasparakis and Naomi Rosenberg. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact